STACEY LYNCH: Open Payments
NPI 1750705513 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 22 payments from 10 companies in 2025. Trend: 2023 $2,767 · 2024 $935 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $34 |
| Tris Pharma Inc | 2 | $33 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
Products named: SPRAVATO, REXULTI, CAPLYTA, Auvelity, INGREZZA, Dyanavel XR, ABILIFY ASIMTUFII, NUPLAZID.
Industry payments across AR — which companies pay providers there.
